- 01 Aug 2023
- Cold Call Podcast
Can Business Transform Primary Health Care Across Africa?
mPharma, headquartered in Ghana, is trying to create the largest pan-African health care company. Their mission is to provide primary care and a reliable and fairly priced supply of drugs in the nine African countries where they operate. Co-founder and CEO Gregory Rockson needs to decide which component of strategy to prioritize in the next three years. His options include launching a telemedicine program, expanding his pharmacies across the continent, and creating a new payment program to cover the cost of common medications. Rockson cares deeply about health equity, but his venture capital-financed company also must be profitable. Which option should he focus on expanding? Harvard Business School Professor Regina Herzlinger and case protagonist Gregory Rockson discuss the important role business plays in improving health care in the case, “mPharma: Scaling Access to Affordable Primary Care in Africa.”
- 24 Feb 2022
- Op-Ed
Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC
After two years of COVID-19, many hospitals still haven't figured out how to manage the overwhelming wave of patients that flood ICUs during each surge. Regina Herzlinger and Richard Boxer offer a novel solution. Open for comment; 0 Comments.
- 19 Jan 2022
- In Practice
7 Trends to Watch in 2022
Surging COVID-19 cases may have dampened optimism at the start of 2022, but change could be on the horizon. Harvard Business School faculty members share the trends they're watching this year. Open for comment; 0 Comments.
- 24 Nov 2020
- Cold Call Podcast
Evaluating Innovative Health Care Solutions for Obesity
From Weight Watchers to bariatric surgery, innovations for combatting obesity abound. But which will do the most good for society and yield the best business results? Professor Regina Herzlinger discusses a new case study. Open for comment; 0 Comments.
- 08 Sep 2020
- Sharpening Your Skills
Capitalism Works Better When I Can See What You're Doing
Lower prices. More innovation. Better government. Transparency fuels the basic principles of competitive business and open government. Well, most of the time. Open for comment; 0 Comments.
- 03 Sep 2020
- Op-Ed
Why American Health Care Needs Its Own SEC
The United States needs a health care equivalent of the Securities and Exchange Commission to increase transparency and competition, argues Regina Herzlinger. Open for comment; 0 Comments.
- 20 Jul 2020
- Op-Ed
It's Time for a Bipartisan Health Plan for Employers and Employees
Regina E. Herzlinger and Richard J. Boxer prescribe a seemingly impossible cure for battling health care options: a plan that embraces both Republican and Democratic ideas. Open for comment; 0 Comments.
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
The coronavirus pandemic might lead to major changes in patient care, physician compensation, and regulation. Experts from Harvard Business School's Health Care Initiative share their predictions. Open for comment; 0 Comments.
- 20 Feb 2020
- Op-Ed
Love in the Office Is Wonderful. Except for CEOs.
Finding love among your office colleagues can be a wonderful thing, and not inevitably career ending. Unless, of course, you are the CEO. Advice to the corporate lovelorn from Regina Herzlinger. Open for comment; 0 Comments.
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
A public insurance option could use its scale to hold prices down, but only if the approach avoids the financing gimmicks that are undermining Medicare, say Regina E. Herzlinger and James Wallace. Open for comment; 0 Comments.
- 09 May 2017
- First Look
New Research and Ideas, May 9
How Do You Reorg Big Bird? ... Organized for a downturn ... Finding a new market for Fitbit.
- 20 Apr 2017
- Cold Call Podcast
Making Health Insurance That Consumers Actually Like
By motivating its insurance customers to take care of themselves, South African firm Vitality has expanded to the United Kingdom and China. In this podcast, Professor Regina Herzlinger discusses potential impacts of this model for health care in the United States. Open for comment; 0 Comments.
- 21 Nov 2012
- Research & Ideas
What Health Care Managers Need to Know--and How to Teach Them
Health care business managers are under tremendous pressure to become more innovative, more productive, more accountable. The question, asks Regina Herzlinger, is who is going to teach them these skills? Open for comment; 0 Comments.
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
We asked three Harvard Business School faculty members, all experts in the health care field, to provide their views on various facets of one of this country's most important and complex problems. Open for comment; 0 Comments.
- 07 Oct 2011
- Research & Ideas
The Steve Jobs Legacy
Harvard Business School faculty offer their perspectives on the legendary career of Steve Jobs, who remade several industries even as he changed how we use technology. Closed for comment; 0 Comments.
- 04 Jul 2011
- Research & Ideas
Making the Case for Consumer-Driven Health Care
Even as so-called Obamacare becomes a central issue in the 2012 presidential election, policymakers and academics continue the debate on how best to deliver affordable and efficient health care services to millions of Americans. In this video interview, professor Regina Herzlinger makes the case that consumers should have more say over their own care. Closed for comment; 0 Comments.
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
With deep experience in health insurance reform, HBS faculty describe how improved competition in insurance plans could improve value for patients. Professors Regina E. Herzlinger, Robert Huckman, and Michael E. Porter take the pulse of a debate. Key concepts include: "A government market with an underpriced Medicare would likely lead to the death of private-sector markets and products," say Professor Regina E. Herzlinger and coauthor Tom Coburn (R-OK). Patients would like the option of a public insurance plan, according to Professor Robert Huckman. Competition among insurers should be based on improving patients' health outcomes achieved per dollar spent, writes Professor Michael E. Porter. Closed for comment; 0 Comments.
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
Professor Regina Herzlinger has been studying the US health care system for decades, advocating for consumer-driven reform as the best remedy. But the slow pace of change, which she attributes to a fat-cat network of insurers, policymakers, hospitals, and even employers, has her fed up. Her new book, Who Killed Health Care? adopts the emotional language of a manifesto in demanding change to make health care more responsive to customers, affordable to those in need, and a hotbed of innovation and entrepreneurship. Closed for comment; 0 Comments.
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
Perhaps no industry has caught the research attention of Harvard Business School faculty as much as health care. Researchers are investigating business-focused solutions on everything from improving team work among surgical teams to developing market motivations that increase the use of water purification in poor villages. Key concepts include: The $2 trillion American health care system has grown bloated and overly expensive, and it delivers poor service to many patients. Harvard Business School faculty are looking at the system through a business management perspective to recommend changes in almost all aspects of health care research and delivery. Around the world, HBS researchers are studying ways to improve medical services to the poor using techniques that include everything from motivational marketing to microfinance. Closed for comment; 0 Comments.
Slim Chance: Drugs Will Reshape the Weight Loss Industry, But Habit Change Might Be Elusive
Medications such as Ozempic, Wegovy, and Mounjaro have upended a $76 billion industry that has long touted lifestyle shifts as a means to weight loss. Regina Herzlinger says these drugs might bring fast change, especially for busy professionals, but many questions remain unanswered.